Related Experiment Video
Updated: Jun 22, 2026

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
[Microscopic polyangiitis as etiology for lung fibrosis--a known but often late-diagnosed cause]
Daniela Rosa Gompelmann1, Heinrich Wenz, Claus Peter Heussel
1Pneumologie, Thoraxklinik Heidelberg, Heidelberg, Germany. daniela.gompelmann@thoraxklinik-heidelberg.de
Background And Purpose:
Lung fibrosis as first symptomatic manifestation of microscopic polyangiitis (MPA) is rare. It is characterized by progressive exertional dyspnea, radiologic detection of reticular shadowing, and increased titers of MPA-associated autoantibodies. This case study shall remind of the rare treatable cause of lung fibrosis.
Case Report:
A 78-year-old male patient with long-standing exertional dyspnea and typical chest radiograph appearances of advanced lung fibrosis is presented. The finding of MPA autoantibodies in laboratory tests was decisive to confirm the diagnosis of MPA, and a therapy adapted to the disease severity could be initiated.
Conclusion:
An early diagnosis of MPA and a fast onset of therapy are important, because the influence of an already existent lung fibrosis is uncertain.
Insights
Microscopic polyangiitis (MPA) can rarely present as lung fibrosis with exertional dyspnea. Early diagnosis and treatment of MPA are crucial for managing this rare but treatable cause of lung disease.
Area of Science:
- Pulmonology
- Rheumatology
- Internal Medicine
Background:
- Microscopic polyangiitis (MPA) is a rare autoimmune vasculitis.
- Lung fibrosis as the initial symptomatic presentation of MPA is uncommon.
- MPA is characterized by progressive exertional dyspnea, reticular shadowing on chest imaging, and elevated MPA-associated autoantibodies.
Observation:
- A 78-year-old male presented with chronic exertional dyspnea.
- Chest radiography revealed advanced lung fibrosis.
- Laboratory tests detected MPA-associated autoantibodies, confirming the diagnosis.
Findings:
- The patient was diagnosed with microscopic polyangiitis (MPA).
- Treatment was initiated based on disease severity.
- The presence of autoantibodies was key to diagnosis.
Implications:
- Highlights MPA as a rare but treatable cause of lung fibrosis.
- Emphasizes the importance of early diagnosis of MPA.
- Underscores the need for prompt therapeutic intervention in suspected MPA cases, as the impact of pre-existing lung fibrosis on outcomes is uncertain.
Related Concept Videos
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Other Pulmonary Disorders

